USPTO Launches New Post-Prosecution Pilot Program
The United States Patent and Trademark Office (USPTO) launched a new Post-Prosecution Pilot (P3) on July 11, 2016. According to the USPTO, P3 was initiated to test its impact on enhancing patent…
$200 Million patent infringement judgment in Merck v. Gilead overturned due to misconduct
Federal District judge Beth Labson Freeman has ruled on the drug patent dispute between Gilead Sciences, Inc and Merck & Co, Inc. Judge Freeman has reversed the jury’s patent infringement…
Intellectual Property and Fitbit v. Jawbone
On Thursday April 29th, the U.S. International Trade Commission (ITC) invalidated a number of Jawbone patents, which have been the subject of the ongoing legal dispute between Fitbit and Jawbone. The…